Page last updated: 2024-08-26

lysophosphatidic acid and Hypertrophy

lysophosphatidic acid has been researched along with Hypertrophy in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Aidinis, V; Rai, V; Ray, R; Sinha, S1
Ding, W; Li, H; Liu, XY; Sun, W; Sun, XJ; You-Zhuan, X; Zhang, K; Zhao, CQ; Zhao, J1
Chen, C; Du, L; Han, C; Li, X; Qin, A; Zhang, K; Zhao, C; Zhao, J; Zhou, T1
Boyan, BD; Denison, TA; Hurst-Kennedy, J; Schwartz, Z1
Wei, L1
Cai, Y; Chen, J; Chen, X; Chen, Y; Cong, X; Deng, L; Han, B; Han, Y; Hu, S; Xu, R; Yang, Y; Zhu, W1

Other Studies

6 other study(ies) available for lysophosphatidic acid and Hypertrophy

ArticleYear
Atx regulates skeletal muscle regeneration via LPAR1 and promotes hypertrophy.
    Cell reports, 2021, 03-02, Volume: 34, Issue:9

    Topics: Animals; Cell Line; Female; Gene Expression Regulation; Humans; Hypertrophy; Lysophospholipids; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle Development; Muscle, Skeletal; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Regeneration; Ribosomal Protein S6 Kinases; Satellite Cells, Skeletal Muscle; Signal Transduction; Skeletal Muscle Enlargement; TOR Serine-Threonine Kinases

2021
Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1.
    Clinical spine surgery, 2017, Volume: 30, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Connective Tissue Growth Factor; Female; Fibrosis; Humans; Hypertrophy; Ligamentum Flavum; Lysophospholipids; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Lysophosphatidic Acid; Spinal Stenosis; Statistics as Topic; Young Adult

2017
Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 45, Issue:4

    Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclin-Dependent Kinases; G2 Phase Cell Cycle Checkpoints; Humans; Hypertrophy; Isoxazoles; Ligamentum Flavum; Lumbar Vertebrae; Lysophospholipids; Male; Phosphorylation; Propionates; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction

2018
24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha,25(OH)2D3 in hypertrophic cells.
    The Journal of steroid biochemistry and molecular biology, 2010, Volume: 121, Issue:1-2

    Topics: 24,25-Dihydroxyvitamin D 3; Animals; Apoptosis; Calcitriol; Caspase 3; Cell Proliferation; Chondrocytes; Enzyme Activation; Growth Plate; Hypertrophy; Lysophospholipids; Male; Phospholipases A2; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53

2010
Lysophospholipid signaling in cardiac myocyte hypertrophy.
    Journal of molecular and cellular cardiology, 2004, Volume: 36, Issue:4

    Topics: Animals; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Hypertrophy; Lysophospholipids; Models, Biological; Myocardium; Myocytes, Cardiac; Receptors, G-Protein-Coupled; rho GTP-Binding Proteins; Signal Transduction

2004
Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
    Journal of cellular biochemistry, 2008, Apr-15, Volume: 103, Issue:6

    Topics: Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Diphosphates; Enzyme Inhibitors; Female; Glycerol; Hypertrophy; Lysophospholipids; MAP Kinase Signaling System; Myocardial Infarction; Myocytes, Cardiac; NF-kappa B; Organothiophosphates; Phosphatidic Acids; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling

2008